Verona jumps after Merck nearing $10 billion acquisition

Verona Pharma

09/07/2025 11:54

Updates

** U.S.-listed shares of lung therapy firm Verona Pharma VRNA.O I9SAy.F rise 20.3% to $104.47 premarket

** Merck MRK.N is nearing a deal worth about $10 billion to buy UK-based Verona, companies say

** Merck will pay $107 per American depository share for Verona

** The reported purchase price will be at a premium of about 23% to Verona ADS' last close

** The Financial Times first reported the deal to acquire Verona earlier on Wednesday

** Up to last close, stock up 87% YTD

 (Reporting by Christy Santhosh and Siddhi Mahatole)

 ((Christy.Santhosh@thomsonreuters.com))